UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: IMAkoanaa-400mg-Tablet-SE-IS-MPD-BBDL

Imatinib Koanaa 400 mg Filmdragerad tablett

MPID: SE-100004108-00053085
EURDID: 1725

Full name: Imatinib Koanaa 400 mg Filmdragerad tablett

- Invented name part: Imatinib Koanaa

- Strength part: 400 mg

- Pharmaceutical dose form part: Filmdragerad tablett

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Film-coated tablet

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000093533 L01EA01

Marketing Authorisation 1 of 1

Authorisation number: 53085

Region: Kingdom of Sweden

Marketing authorisation holder: Zentiva k.s.

Identifier:

  • LOC-100002580

Status: Valid (2016-12-22)

Package 1 of 1

PCID:

Description:
Blister, 30 tabletter

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 10 Tablet

Package: 1 Box (Cardboard)

Containing:

Package: 3 Blister (PolyVinyl Chloride) (PolyVinylidene Chloride) (Aluminium)

Containing: 10 Tablet

Manufactured Item

Dose form: Film-coated tablet

Unit of presentation: Tablet

Ingredient

Role: Active

Substance: Imatinib mesilate

Presentation strength: 478 milligram(s) / 1 unit(s)

Reference strength:
Imatinib 400 milligram(s) / 1 unit(s)

Administrable Product (1 of 1)

Dose form: Film-coated tablet

Unit of presentation:

Route of administration:

  • Oral use

Ingredients:

Ingredient

Role: Active

Substance: Imatinib mesilate

Presentation strength: 478 milligram(s) / 1 unit(s)

Reference strength:
Imatinib 400 milligram(s) / 1 unit(s)